Objective: To examine hemodynamic changes following endovascular embolization in newborn infants with vein of Galen malformation and severe cardiac failure in the first week of life.
Introduction
Vein of Galen aneurysmal malformation (VGAM) is a vascular malformation within the brain, which results in a high-flow arteriovenous fistula, and can lead to high-output cardiac failure. It is a rare but life-threatening congenital abnormality, which may present at varying time points in infancy and childhood depending upon the severity of the associated hemodynamic disturbance. 1 Presentation in the newborn period is usually associated with severe congestive heart failure, which often rapidly progresses to multi-system organ failure. 1, 2 Before the use of endovascular embolization, the mortality for VGAMs presenting in the neonatal period was close to 100%. 1, 3 The perinatal hemodynamic changes in these patients are complex and are the result of arteriovenous shunting through the aneurysm. In utero, the low resistance utero-placental circuit protects the fetus by diminishing flow through the low resistance cerebral aneurysm. 4 With loss of the placenta at birth, up to 70% of cardiac output is directed to the low resistance cerebral circulation, with retrograde flow in the proximal descending aorta (isthmus). 4, 5 The increase in venous return leads to right heart overload. There is often right to left shunting at atrial level and also into the descending aorta via the ductus, which usually remains patent. This results in arterial hypoxemia and high-output biventricular failure. 2, 4, 6 A large shunt through the VGAM continues during diastole causing retrograde flow in the descending aorta. This results in a 'steal' phenomenon, which also occurs in utero and can result in cerebral infarction before birth. [4] [5] [6] [7] It also reduces arterial blood flow to most organs including the myocardium, particularly in diastole, and results in myocardial ischemia. 2, 8 Cardiac failure therefore progressively worsens leading to poor peripheral perfusion, lactic acidosis and ultimately multi-system organ failure. 2 In the past decade, advances in endovascular embolization techniques have led to a reduced mortality and morbidity in infants with VGAM, presenting early with cardiac failure. 1, 3, 9 However, there is no recognized optimal medical management strategy for this condition, 9 and little is known about the hemodynamic changes associated with such endovascular intervention. The clinical course and outcome of most of our infants with severe cardiac failure related to VGAM managed at our center with urgent embolization have been reported previously. 8 The purpose of this paper is threefold: to describe the hemodynamic changes following repeated embolization procedures during the neonatal period; to examine the relationship between these hemodynamic changes and hypoxic-ischemic cerebral injury in these infants; and to hypothesize regarding the effect of medical and endovascular treatment on the cerebral circulation.
Materials and methods
Case records of all newborn infants managed at this center between 1996 and 2001 with a diagnosis of choroidal VGAM causing cardiac failure in the early neonatal period were reviewed. The following information was obtained: hemodynamic measurements (heart rate and blood pressure); medical management, including drugs used as antifailure, supportive or antihypertensive therapy; initial and followup neuro-imaging using magnetic resonance imaging (MRI) or computed tomography (CT); and the neurological complications during the initial hospital stay. All patients were followed up clinically by one of the authors at between 3 and 6 years of age.
Parents were counseled against proceeding with endovascular procedures if there was evidence of pre-existing major cerebral damage. However, multi-system organ failure on presentation was not considered a contraindication to such treatment if intensive medical management could render the infant stable enough to undergo these procedures.
Heart rate and blood pressure measurements were obtained with a Merlin module (M1166A, Hewlett Packard Pty Ltd, Andover, MA, USA). Hourly systolic, diastolic and mean blood pressures, together with pulse rates, were recorded. All measurements were obtained from indwelling arterial catheters. Infants were excluded from this data analysis if no endovascular procedure was needed during the first hospital admission, or if death occurred before the completion of one such procedure, as no useful hemodynamic data were available in these cases. Infants were transferred from The Royal Children's Hospital to The Royal Melbourne Hospital for embolization, a distance of 1 km, by a specialized neonatal transport service.
The embolization procedures utilized a number of different types of embolic coils and/or N-butyl 2-cyanoacrylate (NBCA) glue, diluted with lipiodol, using a combination of transvenous, transarterial (femoral) and transtorcular approaches. 10 Cardiovascular parameters measured both before and after the endovascular procedures were compared. The mean arterial blood pressure (MBP) was expressed as the mean of hourly measurements over the preceding 6-h period. Endovascular procedures were included in the statistical analysis only if intraarterial blood pressure monitoring was available for 24 h before and 72 h after the procedure. Hemodynamic data relating to these procedures in individual patients were combined to examine the effect of the endovascular procedure on blood pressure using oneway repeated measures analysis of variance (ANOVA). Significant differences were localized with a multiple comparison test (Dunnett's method), using averaged MBP in the 6 h before the procedure as the control measurement. P-values <0.05 were regarded as significant.
Results

Patients, neuro-imaging and outcome
Nine infants with a diagnosis of choroidal VGAM presenting with cardiac failure in the first week of life were identified (Table 1) . Two were excluded from the hemodynamic data analysis: one infant, (case 1) died on day 2 during the first embolization with multi-system organ failure, and the other (case 5) had delayed embolization after successful medical treatment for cardiac failure.
Two infants had abnormal MRIs before treatment (Table 1) . One, the only premature infant (case 9), was a twin (33 weeks gestation, birth weight 1.6 kg), whose embolization was delayed because of prematurity. The aim was to achieve a body weight of 3 kg, owing to anticipated technical difficulties performing these procedures in a low birth weight infant. On day 55, before embolization, seizures occurred and an MRI showed a right occipital infarct. Another infant (case 2) had hemorrhagic infarcts in the right and left temporo-parietal regions on the initial MRI prior to embolization. Parents of both infants were given the option of withholding further treatment, but opted to proceed.
The overall mortality in this series was 33% (3/9). Five of the six survivors (83%) were neurologically normal or near normal at follow-up ( Table 1) . One of these five infants (case 9) had an isolated homonymous hemianopia, but was otherwise normal neurologically. The sixth infant (case 2) had a seizure disorder together with moderate developmental delay and cerebral palsy.
The two infants excluded from the hemodynamic analysis are included in these outcome statistics.
Medical and endovascular management
The medical management used in eight of these nine infants has been reported previously. 8 Briefly, during the 5-year period of the study, multi-system organ failure was managed increasingly with vasodilator agents, rather than with escalating doses of inotropic drugs (Table 1) . Intensive inotropic support was associated with myocardial ischemia and worsening lactic acidosis. 8 Inhaled nitric oxide and high-frequency ventilation were used in those infants with severe pulmonary hypertension, and prostaglandin E 1 was given to maintain ductal patency in this group of infants. This was to avoid overwhelming right heart failure, which may occur in infants with a high cardiac output and severe pulmonary hypertension. 11, 12 The seven infants included in the hemodynamic analysis had at least one and up to four endovascular procedures during the first hospitalization because of worsening cardiac failure despite maximal medical therapy (Table 1) . A total of 19 embolization procedures were performed.
Hemodynamic observations
An increase in mean arterial pressure was seen following 13 (68%) of the 19 endovascular procedures (Figures 1 and 2) , without any significant change in heart rate. Five infants (Figure 1 ) had mild to moderate hypertension and were not treated with antihypertensive agents. The increase in MBP over the time period from 24 h before until 72 h after the endovascular procedures was significant (ANOVA, P ¼ 0.002). However, the multiple comparison test did not localize this increase to any particular time point compared to control measurements before the procedure. Four of these five infants had received a vasodilator agent during their stabilization before the first procedure. This preceded the onset of hypertension and was commenced early, before embolization, in order to stabilize the infant by improving peripheral perfusion and controlling cardiac failure by reducing after-load. 8 The follow-up neuro-imaging in these five infants showed no abnormality, apart from pre-existing lesions found on CT or MRI (cases 2 and 9) before the first endovascular procedures ( Table 1) .
The other two infants both developed severe hypertension following the third procedure (Figure 2 ). The increase in MBP was highly significant (ANOVA, P<0.001), and the multiple comparison test demonstrated a significant increase in MBP between 48 and 72 h after the procedure (P<0.05). Each was given an intravenous vasodilator, either sodium nitroprusside (case 6) or glyceryl trinitrate (case 8), specifically titrated to lower blood pressure. These two infants subsequently developed intractable seizures. Both suffered severe bilateral cerebral hypoxic-ischemic injury and active treatment was ultimately withdrawn ( Table 1) . The neuro-imaging in both cases showed total infarction of both cerebral hemispheres with complete sparing of the brain stem and cerebellum (Figure 3a and b) .
Discussion
Without embolization the mortality of infants with VGAM and early cardiac failure is close to 100%. 1, 3, 9 Comparison of outcomes between different centers is difficult because selection criteria for endovascular treatment are so variable. 13 The infants in our series were all critically ill and represent a subgroup generally regarded as having the worst prognosis.
8,13-15 They may not have been offered endovascular intervention in many centers. [14] [15] [16] [17] We offered such treatment to all infants with VGAM, including those with multisystem organ failure, provided intensive medical management could stabilize them sufficiently to undergo the procedure. Five of our nine infants also had multi-system organ failure. The overall mortality was 33, and 83% of our survivors were neurologically normal or near normal at clinical follow-up (Table 1) . These figures are comparable to the best outcome data reported for this condition. 16 This suggests that if there is no pre-existing brain injury, severe cardiac failure does not necessarily imply a poor prognosis, but rather the need for early endovascular intervention.
Changes in arterial blood pressure have been reported immediately after embolization of large feeding vessels, but these changes were transient. 8 However, the gradual onset of severe systemic hypertension over the 24-48 h following embolization, which we observed in some infants, has not been reported previously. Two infants in this series (cases 6 and 8) developed severe hypertension after transarterial embolization and were treated with rapidly acting intravenous antihypertensive drugs.
Both subsequently developed intractable seizures owing to almost complete infarction of both cerebral hemispheres, with sparing of the brainstem and cerebellum. This pattern of bilateral encephalomalacia, the 'melting brain' syndrome, has been described in infants with high-flow intracranial shunts. Venous hypertension has been proposed as the cause. 17 However, cerebral venous hypertension in VGAM is caused by the large arteriovenous shunt. When feeding arteries are embolized, the arteriovenous shunt is decreased. This should result in a fall rather than a rise in cerebral venous pressure. Therefore, the cerebral infarction seen in these infants is not likely to be owing to venous infarction alone.
The mechanism for the observed gradual onset of severe systemic hypertension after embolization is unknown. We speculate that this hypertension may provide a protective mechanism to maintain adequate cerebral blood flow (CBF) and perfusion to the newly perfused areas of the brain. The hypertension could be a consequence of reperfusion injury to the cerebral hemispheres after blood flow through the VGAM is suddenly decreased. 18, 19 Current understanding of CBF in newborn infants is that under normal physiological circumstances, variations in arterial blood pressure have little effect on CBF. This pressure-flow autoregulation is intact in the normal newborn infant. 20 In sick newborns, such as those with birth asphyxia, autoregulation may be impaired. 20, 21 Moreover, CBF is also determined by both the resistance to blood flow in cerebral vascular channels and the net pressure gradient across the vascular bed between cerebral arterial and venous pressure, the cerebral perfusion pressure (CPP). 22 In infants with VGAM who have undergone transarterial endovascular procedures, the total cerebral vascular resistance may be increased with little or no change in CPP. Redistribution of regional CBF will then occur to the cerebral hemispheres, which have previously been poorly perfused owing to the 'steal' phenomenon. 7 Reperfusion injury with its associated inflammatory response and cytotoxic edema may further impair CBF to these areas. 19 We postulate that the systemic hypertension observed in these two infants may have represented a physiological response to maintain CBF and regional cerebral perfusion. In this setting, particularly if the VGAM is still causing venous hypertension, drugs administered to lower systemic arterial pressure could cause CBF to be severely impaired, leading to widespread cerebral infarction.
The usual reference range for 'normal' blood pressure under these circumstances becomes non-applicable, and treatment of this hypertension could be detrimental to cerebral perfusion. Unfortunately, direct evidence to substantiate these hypotheses is difficult to obtain. However, the two infants whose arterial blood pressure was lowered using vasodilator agents both developed cerebral infarction. It is unlikely that the hypertension observed was caused by grossly elevated intracranial pressure secondary to cerebral infarction caused at the time of the embolization, as this would have led to infarction of the brain stem and cerebellum as well. Likewise, a severe global hypoxic insult occurring during or after embolization would also not spare the posterior fossa structures.
A similar dilemma, namely whether or not to deliberately lower the blood pressure of patients with possible cerebral edema, is faced by physicians treating adults with acute ischemic stroke. 23 Several authors have recommended that such hypertension should not be treated in order to preserve CBF. [23] [24] [25] [26] [27] [28] Indeed, there have also been recommendations that drugs be used to deliberately elevate blood pressure in these circumstances. 29 Staged transarterial embolizations are required in most of these infants because angiogram dye constraints limit the number of arteries, which can be embolized at any one sitting. 3 For future infants with VGAM, we intend to perform MRI with diffusion weighted images about 24-48 h after each endovascular procedure. 30 This may provide information as to which procedure was responsible for any resulting cerebral infarction, and may enable alterations to the timing of procedures, the number of feeding arteries to be embolized or to the materials used for embolization (metal coils and/or NBCA-lipiodol glue).
Since the early 1990s, the poor prognosis for infants with VGAM presenting with cardiac failure in the neonatal period has improved substantially in the few specialized centers which offer early intervention. 1, 3, 8, 13, 16 There is still, however, no wellrecognized total management strategy for these infants. 9 In a previous paper, we discussed the use of vasodilator agents in the management of VGAM, and it was stated that peripheral vasodilatation could be valuable following endovascular procedures to reduce the occurrence of cerebral hyperperfusion. 8 However, this hemodynamic analysis provides evidence to suggest that vigorous treatment of severe hypertension following endovascular embolization is contraindicated, and may contribute to the development of widespread cerebral infarction in some infants following these procedures.
